Gastro Esophageal Junction Cancer

Also known as: Gastroesophageal-junction Cancer / Gastroesophageal Junction Cancer / Gastro-oesophageal Junction Cancer / Gastro-esophageal Junction Cancer / Gastrooesophageal junction cancer / Carcinoma of oesophagus NOS / Carcinoma of oesophagus / Carcinoma of esophagus (disorder) / Carcinoma of esophagus / Oesophageal carcinoma NOS / Oesophageal carcinoma / Esophageal carcinoma NOS / Esophageal carcinoma / Primary malignant neoplasm of esophagus (disorder)

Drug Trials

Drug	Drug Name	Drug Description

Drug	Drug Name	Target	Type

Drug	Drug Name	Phase	Status	Count
DB00515	Cisplatin	0	Completed	1
DB00445	Epirubicin	0	Completed	1
DB00544	Fluorouracil	0	Completed	1
DB16105	Bemarituzumab	1	Recruiting	1
DB11666	Buparlisib	1	Completed	1
DB00650	Leucovorin	1	Not Yet Recruiting	1
DB09035	Nivolumab	1	Not Yet Recruiting	1
DB09035	Nivolumab	1	Recruiting	1
DB00526	Oxaliplatin	1	Not Yet Recruiting	1
DB09037	Pembrolizumab	1	Not Yet Recruiting	1
DB09143	Sonidegib	1	Completed	1
DB00072	Trastuzumab	1	Not Yet Recruiting	1
DB01101	Capecitabine	1 / 2	Active Not Recruiting	1
DB01248	Docetaxel	1 / 2	Active Not Recruiting	1
DB00526	Oxaliplatin	1 / 2	Active Not Recruiting	1
DB01229	Paclitaxel	1 / 2	Recruiting	1
DB15036	Sitravatinib	1 / 2	Active Not Recruiting	1
DB15133	Tepotinib	1 / 2	Recruiting	1
DB14922	Tislelizumab	1 / 2	Active Not Recruiting	2
DB15043	Toripalimab	1 / 2	Not Yet Recruiting	1
DB11881	AUY922	2	Completed	1
DB08916	Afatinib	2	Active Not Recruiting	1
DB08916	Afatinib	2	Completed	1
DB11885	Anlotinib	2	Recruiting	1
DB11595	Atezolizumab	2	Recruiting	1
DB01101	Capecitabine	2	Completed	1
DB01101	Capecitabine	2	Recruiting	1
DB01101	Capecitabine	2	Terminated	1
DB00958	Carboplatin	2	Active Not Recruiting	1
DB00958	Carboplatin	2	Completed	1
DB00515	Cisplatin	2	Completed	1
DB00515	Cisplatin	2	Terminated	1
DB00515	Cisplatin	2	Unknown Status	1
DB01248	Docetaxel	2	Completed	1
DB01248	Docetaxel	2	Recruiting	1
DB01248	Docetaxel	2	Unknown Status	1
DB16604	Fibrin	2	Completed	1
DB00544	Fluorouracil	2	Active Not Recruiting	1
DB00762	Irinotecan	2	Completed	1
DB00650	Leucovorin	2	Active Not Recruiting	1
DB15191	MAX-40279	2	Recruiting	1
DB09074	Olaparib	2	Recruiting	1
DB00526	Oxaliplatin	2	Active Not Recruiting	1
DB00526	Oxaliplatin	2	Completed	1
DB00526	Oxaliplatin	2	Recruiting	1
DB01229	Paclitaxel	2	Active Not Recruiting	2
DB01229	Paclitaxel	2	Completed	1
DB01229	Paclitaxel	2	Terminated	2
DB01269	Panitumumab	2	Completed	1
DB09037	Pembrolizumab	2	Recruiting	2
DB05578	Ramucirumab	2	Terminated	1
DB00398	Sorafenib	2	Completed	1
DB15043	Toripalimab	2	Recruiting	1
DB00072	Trastuzumab	2	Completed	1
DB00072	Trastuzumab	2	Recruiting	1
DB00072	Trastuzumab	2	Terminated	2
DB01248	Docetaxel	2 / 3	Completed	1
DB00544	Fluorouracil	2 / 3	Completed	1
DB00650	Leucovorin	2 / 3	Completed	1
DB14967	Margetuximab	2 / 3	Active Not Recruiting	1
DB00526	Oxaliplatin	2 / 3	Completed	1
DB06366	Pertuzumab	2 / 3	Completed	1
DB05578	Ramucirumab	2 / 3	Completed	1
DB15766	Retifanlimab	2 / 3	Active Not Recruiting	1
DB16685	Tebotelimab	2 / 3	Active Not Recruiting	1
DB00072	Trastuzumab	2 / 3	Active Not Recruiting	1
DB00072	Trastuzumab	2 / 3	Completed	1
DB01101	Capecitabine	3	Active Not Recruiting	2
DB01101	Capecitabine	3	Recruiting	1
DB00515	Cisplatin	3	Active Not Recruiting	1
DB00515	Cisplatin	3	Recruiting	1
DB01248	Docetaxel	3	Active Not Recruiting	1
DB01248	Docetaxel	3	Recruiting	1
DB00544	Fluorouracil	3	Active Not Recruiting	2
DB00544	Fluorouracil	3	Recruiting	1
DB06186	Ipilimumab	3	Active Not Recruiting	1
DB00762	Irinotecan	3	Terminated	1
DB00650	Leucovorin	3	Active Not Recruiting	2
DB00650	Leucovorin	3	Recruiting	1
DB12155	Napabucasin	3	Completed	1
DB06192	Nimotuzumab	3	Terminated	1
DB09035	Nivolumab	3	Active Not Recruiting	1
DB00526	Oxaliplatin	3	Active Not Recruiting	2
DB00526	Oxaliplatin	3	Recruiting	1
DB01229	Paclitaxel	3	Completed	1
DB09037	Pembrolizumab	3	Active Not Recruiting	1
DB09037	Pembrolizumab	3	Recruiting	1